Elevated menopause proteomic scores are associated with poorer cognitive outcomes and increased risk for Alzheimer disease and dementia.

Semaglutide provides multifaceted kidney protection and improves structural markers in patients with T2D and chronic kidney disease.

Dual-hormone fully closed-loop therapy increases time in glycemic range compared with multiple daily insulin injections (MDI), but not compared with hybrid closed-loop (HCL) therapy in adults with ...

Sustained smoking cessation for at least 8 years significantly reduces risk for microvascular complications in patients with type 2 diabetes.

GLP-1 RAs and SGLT-2 inhibitors reduce risk for renal deterioration in patients with type 2 diabetes (T2D) and albuminuria.

Postoperative benefits include lower odds of major adverse cardiovascular events or infections. HealthDay News — Perioperative glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated ...

Insulin resistance may partially explain the increased long-term cardiovascular risk. HealthDay News — Premature menopause is associated with higher insulin levels and a greater risk for ...

Credit: Getty Images Researchers evaluated recent trends in off-label testosterone prescribing and cardiovascular risk profiles among women in the United States. Rates of off-label testosterone ...

High-dose and long-term oral menopausal hormone therapy significantly elevate risk for venous and arterial thrombotic events, whereas transdermal formulations demonstrate a favorable cardiovascular ...

Concomitant hormone therapy use was linked to more sustained weight loss for midlife women treated for overweight and obesity. HealthDay News — For midlife women treated for overweight or obesity, ...